Skip to content

Spanish Registry on Spontaneous Coronary Artery Dissection

Spanish Registry on Spontaneous Coronary Artery Dissection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03607981
Acronym
SR-SCAD
Enrollment
300
Registered
2018-07-31
Start date
2015-01-01
Completion date
2020-01-01
Last updated
2018-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spontaneous Coronary Artery Dissection

Brief summary

Multicenter observational prospective registry, Spanish nationwide-based, of consecutive patients diagnosed with Spontaneous Coronary Artery Dissection (SCAD)

Detailed description

Multicenter prospective registry on patients with diagnosis of Spontaneous Coronary Artery Dissection (SCAD). Spanish nationwide based, the aims of the current registry are: 1. To analyze predisposing factors, potential triggers and associated pathologies of patients presenting with SCAD. 2. To study the clinical and angiographic presentation of these patients. 3. To analyze the value of intracoronary diagnostic techniques (OCT, IVUS) and non-invasive imaging techniques in the diagnosis of this pathology. 4. To better understand the in-hospital clinical evolution and the response to medical treatment or revascularization in these challenging patients, taking into account the angiographic or intravascular imaging morphological characteristics of SCAD and the treatment applied. 5. To analyze its long-term clinical evolution (adverse cardiovascular events, including recurrence of SCAD). 6. To identify those factors directly related to prognostic and risk of recurrence.

Interventions

None listed

Sponsors

Spanish Society of Cardiology
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Those consecutive patients with a novel diagnosis of Spontaneous Coronary Artery Dissection (SCAD) that, after careful information, accepted to sign the informed consent form.

Exclusion criteria

* Those patients unable to provide informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Predictors of adverse events3 yearsClinical, angiographic and imaging predictors of adverse events during follow-up

Secondary

MeasureTime frameDescription
Predictors of recurrences3 yearsPredictors of recurrences of SCAD at follow-up

Countries

Spain

Contacts

Primary ContactMarcos Garcia-Guimaraes, MD
registronacionaldce@gmail.com0034666681608

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026